“A lot of data on PROTAC research has been disclosed at this event. And also,
many leaders in PROTACs shared their experience and concerns about their
development. Many start-up companies also delivered their progress. We are
able to discuss future directions as well as difficulties with experts from both
industry and the academic area and learned a lot.”

Yuqing Huang Suzhou, Kintor Pharmaceuticals